Williams Jones Wealth Management, Llc. Lineage Cell Therapeutics, Inc. Transaction History
Williams Jones Wealth Management, Llc.
- $8.14 Billion
- Q4 2024
A detailed history of Williams Jones Wealth Management, Llc. transactions in Lineage Cell Therapeutics, Inc. stock. As of the latest transaction made, Williams Jones Wealth Management, Llc. holds 101,300 shares of LCTX stock, worth $43,559. This represents 0.0% of its overall portfolio holdings.
Number of Shares
101,300
Previous 101,300
-0.0%
Holding current value
$43,559
Previous $92,000
45.65%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding LCTX
# of Institutions
137Shares Held
107MCall Options Held
22.1KPut Options Held
0-
Broadwood Capital Inc New York, NY41.7MShares$17.9 Million1.65% of portfolio
-
Black Rock Inc. New York, NY9.56MShares$4.11 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.63MShares$3.71 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY7.24MShares$3.11 Million0.12% of portfolio
-
Defender Capital, Llc.5.96MShares$2.56 Million1.17% of portfolio
About Lineage Cell Therapeutics, Inc.
- Ticker LCTX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 169,755,008
- Market Cap $73M
- Description
- Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...